Knight Therapeutics Inc - 22 Oct 2024 Form 3 Insider Report for Synergy CHC Corp. (SNYR)

Role
10%+ Owner
Signature
KNIGHT THERAPEUTICS INC. By: /s/ Samira Sakhia, President and Chief Executive Officer
Issuer symbol
SNYR
Transactions as of
22 Oct 2024
Net transactions value
$0
Form type
3
Filing time
22 Oct 2024, 20:30:54 UTC
Previous filing
03 Apr 2024
Next filing
13 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SNYR Common Stock, par value $0.00001 per share 1,482,844 22 Oct 2024 Held through Knight Therapeutics International SA, a subsidiary of Knight Therapeutics Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.